Live Attenuated Vaccines Market Report

Global Live Attenuated Vaccines Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 30, 2021
  • PAGES：183
  • REPORT CODE：GMM639700
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

    Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

    The Live Attenuated Vaccines is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Live Attenuated Vaccines market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Live Attenuated Vaccines industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Live Attenuated Vaccines Market Segmentations:

    By Players:

    • GlaxoSmithKline

    • Sanofi

    • Pfizer

    • Merck

    • Serum Institute Of India

    • CSL

    • Johnson & Johnson

    • Astellas Pharma

    By Types:

    • Bacterial

    • Viral

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Live Attenuated Vaccines Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Live Attenuated Vaccines Market Size and Growth Rate of Bacterial from 2014 to 2026

      • 1.3.2 Global Live Attenuated Vaccines Market Size and Growth Rate of Viral from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Live Attenuated Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global Live Attenuated Vaccines Market Size and Growth Rate of Clinics from 2014 to 2026

      • 1.4.3 Global Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes from 2014 to 2026

      • 1.4.4 Global Live Attenuated Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Live Attenuated Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Live Attenuated Vaccines Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Live Attenuated Vaccines by Major Types

      • 3.4.1 Live Attenuated Vaccines Market Size and Growth Rate of Bacterial

      • 3.4.2 Live Attenuated Vaccines Market Size and Growth Rate of Viral

    4 Segmentation of Live Attenuated Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Live Attenuated Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Live Attenuated Vaccines in Hospitals

      • 4.4.2 Market Size and Growth Rate of Live Attenuated Vaccines in Clinics

      • 4.4.3 Market Size and Growth Rate of Live Attenuated Vaccines in Research Institutes

      • 4.4.4 Market Size and Growth Rate of Live Attenuated Vaccines in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Live Attenuated Vaccines Production Analysis by Major Regions

    • 5.2 Global Live Attenuated Vaccines Consumption Analysis by Major Regions

    • 5.3 Global Live Attenuated Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Live Attenuated Vaccines Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

    6 Product Commodity of Live Attenuated Vaccines Market in Major Countries

    • 6.1 Top 5 Export Countries in Live Attenuated Vaccines market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Live Attenuated Vaccines market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Live Attenuated Vaccines market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Live Attenuated Vaccines market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Live Attenuated Vaccines market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Live Attenuated Vaccines market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Live Attenuated Vaccines Landscape Analysis

    • 7.1 North America Live Attenuated Vaccines Landscape Analysis by Major Types

    • 7.2 North America Live Attenuated Vaccines Landscape Analysis by Major End-Users

    • 7.3 North America Live Attenuated Vaccines Landscape Analysis by Major Countries

      • 7.3.1 United States Live Attenuated Vaccines Market Volume and Growth Rate

      • 7.3.2 Canada Live Attenuated Vaccines Market Volume and Growth Rate

      • 7.3.3 Mexico Live Attenuated Vaccines Market Volume and Growth Rate

    8 Europe Live Attenuated Vaccines Landscape Analysis

    • 8.1 Europe Live Attenuated Vaccines Landscape Analysis by Major Types

    • 8.2 Europe Live Attenuated Vaccines Landscape Analysis by Major End-Users

    • 8.3 Europe Live Attenuated Vaccines Landscape Analysis by Major Countries

      • 8.3.1 Germany Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.2 UK Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.3 France Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.4 Italy Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.6 Spain Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.7 Belgium Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.8 Poland Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.9 Russia Live Attenuated Vaccines Market Volume and Growth Rate

      • 8.3.10 Turkey Live Attenuated Vaccines Market Volume and Growth Rate

    9 Asia Pacific Live Attenuated Vaccines Landscape Analysis

    • 9.1 Asia Pacific Live Attenuated Vaccines Landscape Analysis by Major Types

    • 9.2 Asia Pacific Live Attenuated Vaccines Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Live Attenuated Vaccines Landscape Analysis by Major Countries

      • 9.3.1 China Live Attenuated Vaccines Market Volume and Growth Rate

      • 9.3.2 Japan Live Attenuated Vaccines Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Live Attenuated Vaccines Market Volume and Growth Rate

      • 9.3.4 India Live Attenuated Vaccines Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Live Attenuated Vaccines Market Volume and Growth Rate

      • 9.3.6 South Korea Live Attenuated Vaccines Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Live Attenuated Vaccines Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Live Attenuated Vaccines Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Live Attenuated Vaccines Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Live Attenuated Vaccines Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Live Attenuated Vaccines Market Volume and Growth Rate

      • 10.3.2 Brazil Live Attenuated Vaccines Market Volume and Growth Rate

      • 10.3.3 Nigeria Live Attenuated Vaccines Market Volume and Growth Rate

      • 10.3.4 South Africa Live Attenuated Vaccines Market Volume and Growth Rate 

      • 10.3.5 Argentina Live Attenuated Vaccines Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Pfizer

      • 11.3.1 Pfizer Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Merck

      • 11.4.1 Merck Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Serum Institute Of India

      • 11.5.1 Serum Institute Of India Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 CSL

      • 11.6.1 CSL Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Johnson & Johnson

      • 11.7.1 Johnson & Johnson Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Astellas Pharma

      • 11.8.1 Astellas Pharma Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 76 Figures and 177 Tables)

    • Figure Product Picture

    • Figure Live Attenuated Vaccines Market Size and Growth Rate of Bacterial from 2014 to 2026

    • Figure Live Attenuated Vaccines Market Size and Growth Rate of Viral from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • Figure Global Live Attenuated Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Live Attenuated Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Live Attenuated Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Live Attenuated Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Live Attenuated Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Bacterial

    • Figure Market Size and Growth Rate of Viral

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Live Attenuated Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Live Attenuated Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Research Institutes

    • Figure Market Size and Growth Rate of Others

    • Table Global Live Attenuated Vaccines Production by Major Regions

    • Table Global Live Attenuated Vaccines Production Share by Major Regions

    • Figure Global Live Attenuated Vaccines Production Share by Major Regions in 2014

    • Figure Global Live Attenuated Vaccines Production Share by Major Regions in 2018

    • Figure Global Live Attenuated Vaccines Production Share by Major Regions in 2026

    • Table Global Live Attenuated Vaccines Consumption by Major Regions

    • Table Global Live Attenuated Vaccines Consumption Share by Major Regions

    • Figure Global Live Attenuated Vaccines Consumption Share by Major Regions in 2014

    • Figure Global Live Attenuated Vaccines Consumption Share by Major Regions in 2018

    • Figure Global Live Attenuated Vaccines Consumption Share by Major Regions in 2026

    • Table North America Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

    • Table Europe Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Live Attenuated Vaccines market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Live Attenuated Vaccines market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Live Attenuated Vaccines market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Live Attenuated Vaccines market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Live Attenuated Vaccines Consumption by Types from 2014 to 2026

    • Table North America Live Attenuated Vaccines Consumption Share by Types from 2014 to 2026

    • Figure North America Live Attenuated Vaccines Consumption Share by Types in 2014

    • Figure North America Live Attenuated Vaccines Consumption Share by Types in 2018

    • Figure North America Live Attenuated Vaccines Consumption Share by Types in 2026

    • Table North America Live Attenuated Vaccines Consumption by End-Users from 2014 to 2026

    • Table North America Live Attenuated Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure North America Live Attenuated Vaccines Consumption Share by End-Users in 2014

    • Figure North America Live Attenuated Vaccines Consumption Share by End-Users in 2018

    • Figure North America Live Attenuated Vaccines Consumption Share by End-Users in 2026

    • Table North America Live Attenuated Vaccines Consumption by Major Countries from 2014 to 2026

    • Table North America Live Attenuated Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Live Attenuated Vaccines Consumption Share by Major Countries in 2014

    • Figure North America Live Attenuated Vaccines Consumption Share by Major Countries in 2018

    • Figure North America Live Attenuated Vaccines Consumption Share by Major Countries in 2026

    • Figure United States Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Live Attenuated Vaccines Consumption by Types from 2014 to 2026

    • Table Europe Live Attenuated Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Europe Live Attenuated Vaccines Consumption Share by Types in 2014

    • Figure Europe Live Attenuated Vaccines Consumption Share by Types in 2018

    • Figure Europe Live Attenuated Vaccines Consumption Share by Types in 2026

    • Table Europe Live Attenuated Vaccines Consumption by End-Users from 2014 to 2026

    • Table Europe Live Attenuated Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Live Attenuated Vaccines Consumption Share by End-Users in 2014

    • Figure Europe Live Attenuated Vaccines Consumption Share by End-Users in 2018

    • Figure Europe Live Attenuated Vaccines Consumption Share by End-Users in 2026

    • Table Europe Live Attenuated Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Europe Live Attenuated Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Live Attenuated Vaccines Consumption Share by Major Countries in 2014

    • Figure Europe Live Attenuated Vaccines Consumption Share by Major Countries in 2018

    • Figure Europe Live Attenuated Vaccines Consumption Share by Major Countries in 2026

    • Figure Germany Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure France Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Live Attenuated Vaccines Consumption by Types from 2014 to 2026

    • Table Asia Pacific Live Attenuated Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by Types in 2014

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by Types in 2018

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by Types in 2026

    • Table Asia Pacific Live Attenuated Vaccines Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Live Attenuated Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by End-Users in 2014

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by End-Users in 2018

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by End-Users in 2026

    • Table Asia Pacific Live Attenuated Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Live Attenuated Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Live Attenuated Vaccines Consumption Share by Major Countries in 2026

    • Figure China Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandLive Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure India Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Live Attenuated Vaccines Consumption Share by Major Countries in 2026

    • Figure GCC Countries Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Live Attenuated Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Serum Institute Of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute Of India

    • Figure Sales and Growth Rate Analysis of Serum Institute Of India

    • Figure Revenue and Market Share Analysis of Serum Institute Of India

    • Table Product and Service Introduction of Serum Institute Of India

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US